0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dry Eye Syndrome Market Research Report 2026
Published Date: 2026-04-13
|
Report Code: QYRE-Auto-31K8891
Home | Market Reports | Health| Vision Care
Global Dry Eye Syndrome Market Outlook 2022
BUY CHAPTERS

Global Dry Eye Syndrome Market Research Report 2026

Code: QYRE-Auto-31K8891
Report
2026-04-13
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dry Eye Syndrome Market Size

The global Dry Eye Syndrome market was valued at US$ 6115 million in 2025 and is anticipated to reach US$ 8285 million by 2032, at a CAGR of 4.5% from 2026 to 2032.

Dry Eye Syndrome Market

Dry Eye Syndrome Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Dry Eye Syndrome competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment. In this report, we mainly study the drugs and eye drops for dry eye.
The Dry Eye Syndrome market is driven by the rising prevalence of dry eye conditions globally, fueled by aging populations, increased screen time, and lifestyle-related factors. The widespread use of digital devices has significantly contributed to eye strain and reduced blink rates, leading to a surge in dry eye cases, especially among younger demographics. Additionally, growing awareness of ocular health and improved diagnosis through advanced diagnostic tools have increased patient identification and treatment rates. The introduction of innovative therapies, including anti-inflammatory eye drops, tear-stimulating drugs, and device-based treatments, is also expanding the market landscape.
Despite growing demand, the Dry Eye Syndrome market faces several challenges, including underdiagnosis, variable symptoms, and limited long-term treatment efficacy. Many patients remain undiagnosed due to the overlap of symptoms with other ocular conditions and the subjective nature of the disease. Current treatments often offer only temporary relief rather than a cure, leading to poor adherence and patient dissatisfaction. Moreover, the development of new therapies is hindered by the complex pathophysiology of the condition, which involves both aqueous and evaporative components. Addressing these challenges requires improved diagnostic criteria, personalized treatment approaches, and increased investment in research and clinical trials.
Global Dry Eye Syndrome key players include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, etc. Global top five manufacturers hold a share over 60%. North America is the largest market, with a share over 55%, followed by Europe and Asia-Pacific, both have a share over 35 percent. In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital, followed by Retail Pharmacy.
This report delivers a comprehensive overview of the global Dry Eye Syndrome market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dry Eye Syndrome. The Dry Eye Syndrome market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Dry Eye Syndrome market comprehensively. Regional market sizes by Type, by Distribution Channel, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dry Eye Syndrome manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Distribution Channel, and by region.
Market Segmentation

Scope of Dry Eye Syndrome Market Report

Report Metric Details
Report Name Dry Eye Syndrome Market
Accounted market size in 2025 US$ 6115 million
Forecasted market size in 2032 US$ 8285 million
CAGR 4.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Artificial Tears
  • Anti-inflammatory Drugs
  • Others
  • by Distribution Channel
  • Hospital
  • Retail Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, United Laboratories, Sun Pharmaceutical, Jianfeng Group, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Distribution Channel, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Dry Eye Syndrome manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Dry Eye Syndrome sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Distribution Channel, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Dry Eye Syndrome Market growing?

Ans: The Dry Eye Syndrome Market witnessing a CAGR of 4.5% during the forecast period 2026-2032.

What is the Dry Eye Syndrome Market size in 2032?

Ans: The Dry Eye Syndrome Market size in 2032 will be US$ 8285 million.

What is the market share of major companies in Dry Eye Syndrome Market?

Ans: Global top five manufacturers hold a share over 60%.

What is the Dry Eye Syndrome Market share by type?

Ans: In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%.

Who are the main players in the Dry Eye Syndrome Market report?

Ans: The main players in the Dry Eye Syndrome Market are AbbVie, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, United Laboratories, Sun Pharmaceutical, Jianfeng Group, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE)

What are the Type segmentation covered in the Dry Eye Syndrome Market report?

Ans: The Types covered in the Dry Eye Syndrome Market report are Artificial Tears, Anti-inflammatory Drugs, Others, by Distribution Channel, Hospital, Retail Pharmacy

1 Dry Eye Syndrome Market Overview
1.1 Product Definition
1.2 Dry Eye Syndrome by Type
1.2.1 Global Dry Eye Syndrome Market Value by Type: 2025 vs 2032
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Others
1.3 Dry Eye Syndrome by Distribution Channel
1.3.1 Global Dry Eye Syndrome Market Value by Distribution Channel: 2025 vs 2032
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Dry Eye Syndrome Market Size Estimates and Forecasts
1.4.1 Global Dry Eye Syndrome Revenue 2021–2032
1.4.2 Global Dry Eye Syndrome Sales 2021–2032
1.4.3 Global Dry Eye Syndrome Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Dry Eye Syndrome Market Competition by Manufacturers
2.1 Global Dry Eye Syndrome Sales Market Share by Manufacturers (2021–2026)
2.2 Global Dry Eye Syndrome Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Dry Eye Syndrome Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Dry Eye Syndrome, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Dry Eye Syndrome, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Dry Eye Syndrome, Product Types and Applications
2.7 Global Key Manufacturers of Dry Eye Syndrome, Date of Entry into the Industry
2.8 Global Dry Eye Syndrome Market Competitive Situation and Trends
2.8.1 Global Dry Eye Syndrome Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Dry Eye Syndrome Players Market Share by Revenue
2.8.3 Global Dry Eye Syndrome Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dry Eye Syndrome Market Scenario by Region
3.1 Global Dry Eye Syndrome Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Dry Eye Syndrome Sales by Region: 2021–2032
3.2.1 Global Dry Eye Syndrome Sales by Region: 2021–2026
3.2.2 Global Dry Eye Syndrome Sales by Region: 2027–2032
3.3 Global Dry Eye Syndrome Revenue by Region: 2021–2032
3.3.1 Global Dry Eye Syndrome Revenue by Region: 2021–2026
3.3.2 Global Dry Eye Syndrome Revenue by Region: 2027–2032
3.4 North America Dry Eye Syndrome Market Facts & Figures by Country
3.4.1 North America Dry Eye Syndrome Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Dry Eye Syndrome Sales by Country (2021–2032)
3.4.3 North America Dry Eye Syndrome Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dry Eye Syndrome Market Facts & Figures by Country
3.5.1 Europe Dry Eye Syndrome Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Dry Eye Syndrome Sales by Country (2021–2032)
3.5.3 Europe Dry Eye Syndrome Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dry Eye Syndrome Market Facts & Figures by Region
3.6.1 Asia Pacific Dry Eye Syndrome Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Dry Eye Syndrome Sales by Region (2021–2032)
3.6.3 Asia Pacific Dry Eye Syndrome Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dry Eye Syndrome Market Facts & Figures by Country
3.7.1 Latin America Dry Eye Syndrome Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Dry Eye Syndrome Sales by Country (2021–2032)
3.7.3 Latin America Dry Eye Syndrome Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dry Eye Syndrome Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Eye Syndrome Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Dry Eye Syndrome Sales by Country (2021–2032)
3.8.3 Middle East and Africa Dry Eye Syndrome Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dry Eye Syndrome Sales by Type (2021–2032)
4.1.1 Global Dry Eye Syndrome Sales by Type (2021–2026)
4.1.2 Global Dry Eye Syndrome Sales by Type (2027–2032)
4.1.3 Global Dry Eye Syndrome Sales Market Share by Type (2021–2032)
4.2 Global Dry Eye Syndrome Revenue by Type (2021–2032)
4.2.1 Global Dry Eye Syndrome Revenue by Type (2021–2026)
4.2.2 Global Dry Eye Syndrome Revenue by Type (2027–2032)
4.2.3 Global Dry Eye Syndrome Revenue Market Share by Type (2021–2032)
4.3 Global Dry Eye Syndrome Price by Type (2021–2032)
5 Segment by Distribution Channel
5.1 Global Dry Eye Syndrome Sales by Distribution Channel (2021–2032)
5.1.1 Global Dry Eye Syndrome Sales by Distribution Channel (2021–2026)
5.1.2 Global Dry Eye Syndrome Sales by Distribution Channel (2027–2032)
5.1.3 Global Dry Eye Syndrome Sales Market Share by Distribution Channel (2021–2032)
5.2 Global Dry Eye Syndrome Revenue by Distribution Channel (2021–2032)
5.2.1 Global Dry Eye Syndrome Revenue by Distribution Channel (2021–2026)
5.2.2 Global Dry Eye Syndrome Revenue by Distribution Channel (2027–2032)
5.2.3 Global Dry Eye Syndrome Revenue Market Share by Distribution Channel (2021–2032)
5.3 Global Dry Eye Syndrome Price by Distribution Channel (2021–2032)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 AbbVie Dry Eye Syndrome Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Alcon
6.2.1 Alcon Company Information
6.2.2 Alcon Description and Business Overview
6.2.3 Alcon Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Alcon Dry Eye Syndrome Product Portfolio
6.2.5 Alcon Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Novartis Dry Eye Syndrome Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Santen Pharma
6.4.1 Santen Pharma Company Information
6.4.2 Santen Pharma Description and Business Overview
6.4.3 Santen Pharma Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Santen Pharma Dry Eye Syndrome Product Portfolio
6.4.5 Santen Pharma Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Johnson & Johnson Dry Eye Syndrome Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Bausch & Lomb
6.6.1 Bausch & Lomb Company Information
6.6.2 Bausch & Lomb Description and Business Overview
6.6.3 Bausch & Lomb Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Bausch & Lomb Dry Eye Syndrome Product Portfolio
6.6.5 Bausch & Lomb Recent Developments/Updates
6.7 Thea pharmaceuticals
6.7.1 Thea pharmaceuticals Company Information
6.7.2 Thea pharmaceuticals Description and Business Overview
6.7.3 Thea pharmaceuticals Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Thea pharmaceuticals Dry Eye Syndrome Product Portfolio
6.7.5 Thea pharmaceuticals Recent Developments/Updates
6.8 URSAPHARM
6.8.1 URSAPHARM Company Information
6.8.2 URSAPHARM Description and Business Overview
6.8.3 URSAPHARM Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 URSAPHARM Dry Eye Syndrome Product Portfolio
6.8.5 URSAPHARM Recent Developments/Updates
6.9 SIMILASAN
6.9.1 SIMILASAN Company Information
6.9.2 SIMILASAN Description and Business Overview
6.9.3 SIMILASAN Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 SIMILASAN Dry Eye Syndrome Product Portfolio
6.9.5 SIMILASAN Recent Developments/Updates
6.10 Akorn
6.10.1 Akorn Company Information
6.10.2 Akorn Description and Business Overview
6.10.3 Akorn Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Akorn Dry Eye Syndrome Product Portfolio
6.10.5 Akorn Recent Developments/Updates
6.11 United Laboratories
6.11.1 United Laboratories Company Information
6.11.2 United Laboratories Description and Business Overview
6.11.3 United Laboratories Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 United Laboratories Dry Eye Syndrome Product Portfolio
6.11.5 United Laboratories Recent Developments/Updates
6.12 Sun Pharmaceutical
6.12.1 Sun Pharmaceutical Company Information
6.12.2 Sun Pharmaceutical Description and Business Overview
6.12.3 Sun Pharmaceutical Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sun Pharmaceutical Dry Eye Syndrome Product Portfolio
6.12.5 Sun Pharmaceutical Recent Developments/Updates
6.13 Jianfeng Group
6.13.1 Jianfeng Group Company Information
6.13.2 Jianfeng Group Description and Business Overview
6.13.3 Jianfeng Group Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Jianfeng Group Dry Eye Syndrome Product Portfolio
6.13.5 Jianfeng Group Recent Developments/Updates
6.14 OmniVision Pharma
6.14.1 OmniVision Pharma Company Information
6.14.2 OmniVision Pharma Description and Business Overview
6.14.3 OmniVision Pharma Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 OmniVision Pharma Dry Eye Syndrome Product Portfolio
6.14.5 OmniVision Pharma Recent Developments/Updates
6.15 Rohto
6.15.1 Rohto Company Information
6.15.2 Rohto Description and Business Overview
6.15.3 Rohto Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Rohto Dry Eye Syndrome Product Portfolio
6.15.5 Rohto Recent Developments/Updates
6.16 Prestige Consumer Healthcare
6.16.1 Prestige Consumer Healthcare Company Information
6.16.2 Prestige Consumer Healthcare Description and Business Overview
6.16.3 Prestige Consumer Healthcare Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Prestige Consumer Healthcare Dry Eye Syndrome Product Portfolio
6.16.5 Prestige Consumer Healthcare Recent Developments/Updates
6.17 LION
6.17.1 LION Company Information
6.17.2 LION Description and Business Overview
6.17.3 LION Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 LION Dry Eye Syndrome Product Portfolio
6.17.5 LION Recent Developments/Updates
6.18 Kenvue (VISINE)
6.18.1 Kenvue (VISINE) Company Information
6.18.2 Kenvue (VISINE) Description and Business Overview
6.18.3 Kenvue (VISINE) Dry Eye Syndrome Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Kenvue (VISINE) Dry Eye Syndrome Product Portfolio
6.18.5 Kenvue (VISINE) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Eye Syndrome Industry Chain Analysis
7.2 Dry Eye Syndrome Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Eye Syndrome Production Mode & Process Analysis
7.4 Dry Eye Syndrome Sales and Marketing
7.4.1 Dry Eye Syndrome Sales Channels
7.4.2 Dry Eye Syndrome Distributors
7.5 Dry Eye Syndrome Customer Analysis
8 Dry Eye Syndrome Market Dynamics
8.1 Dry Eye Syndrome Industry Trends
8.2 Dry Eye Syndrome Market Drivers
8.3 Dry Eye Syndrome Market Challenges
8.4 Dry Eye Syndrome Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Dry Eye Syndrome Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Dry Eye Syndrome Market Value by Distribution Channel (US$ Million), 2025 vs 2032
 Table 3. Global Dry Eye Syndrome Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Dry Eye Syndrome Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Dry Eye Syndrome Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Dry Eye Syndrome Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Dry Eye Syndrome Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Dry Eye Syndrome Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Dry Eye Syndrome, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Dry Eye Syndrome, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Dry Eye Syndrome, Product Types and Applications
 Table 12. Global Key Manufacturers of Dry Eye Syndrome, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dry Eye Syndrome Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dry Eye Syndrome Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dry Eye Syndrome Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Dry Eye Syndrome Sales by Region (K Units), 2021–2026
 Table 18. Global Dry Eye Syndrome Sales Market Share by Region (2021–2026)
 Table 19. Global Dry Eye Syndrome Sales by Region (K Units), 2027–2032
 Table 20. Global Dry Eye Syndrome Sales Market Share by Region (2027–2032)
 Table 21. Global Dry Eye Syndrome Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Dry Eye Syndrome Revenue Market Share by Region (2021–2026)
 Table 23. Global Dry Eye Syndrome Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Dry Eye Syndrome Revenue Market Share by Region (2027–2032)
 Table 25. North America Dry Eye Syndrome Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Dry Eye Syndrome Sales by Country (K Units), 2021–2026
 Table 27. North America Dry Eye Syndrome Sales by Country (K Units), 2027–2032
 Table 28. North America Dry Eye Syndrome Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Dry Eye Syndrome Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Dry Eye Syndrome Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Dry Eye Syndrome Sales by Country (K Units), 2021–2026
 Table 32. Europe Dry Eye Syndrome Sales by Country (K Units), 2027–2032
 Table 33. Europe Dry Eye Syndrome Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Dry Eye Syndrome Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Dry Eye Syndrome Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Dry Eye Syndrome Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Dry Eye Syndrome Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Dry Eye Syndrome Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Dry Eye Syndrome Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Dry Eye Syndrome Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Dry Eye Syndrome Sales by Country (K Units), 2021–2026
 Table 42. Latin America Dry Eye Syndrome Sales by Country (K Units), 2027–2032
 Table 43. Latin America Dry Eye Syndrome Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Dry Eye Syndrome Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Dry Eye Syndrome Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Dry Eye Syndrome Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Dry Eye Syndrome Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Dry Eye Syndrome Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Dry Eye Syndrome Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Dry Eye Syndrome Sales (K Units) by Type (2021–2026)
 Table 51. Global Dry Eye Syndrome Sales (K Units) by Type (2027–2032)
 Table 52. Global Dry Eye Syndrome Sales Market Share by Type (2021–2026)
 Table 53. Global Dry Eye Syndrome Sales Market Share by Type (2027–2032)
 Table 54. Global Dry Eye Syndrome Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Dry Eye Syndrome Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Dry Eye Syndrome Revenue Market Share by Type (2021–2026)
 Table 57. Global Dry Eye Syndrome Revenue Market Share by Type (2027–2032)
 Table 58. Global Dry Eye Syndrome Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Dry Eye Syndrome Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Dry Eye Syndrome Sales (K Units) by Distribution Channel (2021–2026)
 Table 61. Global Dry Eye Syndrome Sales (K Units) by Distribution Channel (2027–2032)
 Table 62. Global Dry Eye Syndrome Sales Market Share by Distribution Channel (2021–2026)
 Table 63. Global Dry Eye Syndrome Sales Market Share by Distribution Channel (2027–2032)
 Table 64. Global Dry Eye Syndrome Revenue (US$ Million) by Distribution Channel (2021–2026)
 Table 65. Global Dry Eye Syndrome Revenue (US$ Million) by Distribution Channel (2027–2032)
 Table 66. Global Dry Eye Syndrome Revenue Market Share by Distribution Channel (2021–2026)
 Table 67. Global Dry Eye Syndrome Revenue Market Share by Distribution Channel (2027–2032)
 Table 68. Global Dry Eye Syndrome Price (US$/Unit) by Distribution Channel (2021–2026)
 Table 69. Global Dry Eye Syndrome Price (US$/Unit) by Distribution Channel (2027–2032)
 Table 70. AbbVie Company Information
 Table 71. AbbVie Description and Business Overview
 Table 72. AbbVie Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. AbbVie Dry Eye Syndrome Product
 Table 74. AbbVie Recent Developments/Updates
 Table 75. Alcon Company Information
 Table 76. Alcon Description and Business Overview
 Table 77. Alcon Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Alcon Dry Eye Syndrome Product
 Table 79. Alcon Recent Developments/Updates
 Table 80. Novartis Company Information
 Table 81. Novartis Description and Business Overview
 Table 82. Novartis Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Novartis Dry Eye Syndrome Product
 Table 84. Novartis Recent Developments/Updates
 Table 85. Santen Pharma Company Information
 Table 86. Santen Pharma Description and Business Overview
 Table 87. Santen Pharma Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Santen Pharma Dry Eye Syndrome Product
 Table 89. Santen Pharma Recent Developments/Updates
 Table 90. Johnson & Johnson Company Information
 Table 91. Johnson & Johnson Description and Business Overview
 Table 92. Johnson & Johnson Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Johnson & Johnson Dry Eye Syndrome Product
 Table 94. Johnson & Johnson Recent Developments/Updates
 Table 95. Bausch & Lomb Company Information
 Table 96. Bausch & Lomb Description and Business Overview
 Table 97. Bausch & Lomb Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Bausch & Lomb Dry Eye Syndrome Product
 Table 99. Bausch & Lomb Recent Developments/Updates
 Table 100. Thea pharmaceuticals Company Information
 Table 101. Thea pharmaceuticals Description and Business Overview
 Table 102. Thea pharmaceuticals Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Thea pharmaceuticals Dry Eye Syndrome Product
 Table 104. Thea pharmaceuticals Recent Developments/Updates
 Table 105. URSAPHARM Company Information
 Table 106. URSAPHARM Description and Business Overview
 Table 107. URSAPHARM Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. URSAPHARM Dry Eye Syndrome Product
 Table 109. URSAPHARM Recent Developments/Updates
 Table 110. SIMILASAN Company Information
 Table 111. SIMILASAN Description and Business Overview
 Table 112. SIMILASAN Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. SIMILASAN Dry Eye Syndrome Product
 Table 114. SIMILASAN Recent Developments/Updates
 Table 115. Akorn Company Information
 Table 116. Akorn Description and Business Overview
 Table 117. Akorn Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Akorn Dry Eye Syndrome Product
 Table 119. Akorn Recent Developments/Updates
 Table 120. United Laboratories Company Information
 Table 121. United Laboratories Description and Business Overview
 Table 122. United Laboratories Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. United Laboratories Dry Eye Syndrome Product
 Table 124. United Laboratories Recent Developments/Updates
 Table 125. Sun Pharmaceutical Company Information
 Table 126. Sun Pharmaceutical Description and Business Overview
 Table 127. Sun Pharmaceutical Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Sun Pharmaceutical Dry Eye Syndrome Product
 Table 129. Sun Pharmaceutical Recent Developments/Updates
 Table 130. Jianfeng Group Company Information
 Table 131. Jianfeng Group Description and Business Overview
 Table 132. Jianfeng Group Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Jianfeng Group Dry Eye Syndrome Product
 Table 134. Jianfeng Group Recent Developments/Updates
 Table 135. OmniVision Pharma Company Information
 Table 136. OmniVision Pharma Description and Business Overview
 Table 137. OmniVision Pharma Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. OmniVision Pharma Dry Eye Syndrome Product
 Table 139. OmniVision Pharma Recent Developments/Updates
 Table 140. Rohto Company Information
 Table 141. Rohto Description and Business Overview
 Table 142. Rohto Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Rohto Dry Eye Syndrome Product
 Table 144. Rohto Recent Developments/Updates
 Table 145. Prestige Consumer Healthcare Company Information
 Table 146. Prestige Consumer Healthcare Description and Business Overview
 Table 147. Prestige Consumer Healthcare Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Prestige Consumer Healthcare Dry Eye Syndrome Product
 Table 149. Prestige Consumer Healthcare Recent Developments/Updates
 Table 150. LION Company Information
 Table 151. LION Description and Business Overview
 Table 152. LION Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. LION Dry Eye Syndrome Product
 Table 154. LION Recent Developments/Updates
 Table 155. Kenvue (VISINE) Company Information
 Table 156. Kenvue (VISINE) Description and Business Overview
 Table 157. Kenvue (VISINE) Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. Kenvue (VISINE) Dry Eye Syndrome Product
 Table 159. Kenvue (VISINE) Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Dry Eye Syndrome Distributors List
 Table 163. Dry Eye Syndrome Customers List
 Table 164. Dry Eye Syndrome Market Trends
 Table 165. Dry Eye Syndrome Market Drivers
 Table 166. Dry Eye Syndrome Market Challenges
 Table 167. Dry Eye Syndrome Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dry Eye Syndrome
 Figure 2. Global Dry Eye Syndrome Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Dry Eye Syndrome Market Share by Type: 2025 & 2032
 Figure 4. Artificial Tears Product Picture
 Figure 5. Anti-inflammatory Drugs Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Dry Eye Syndrome Market Value by Distribution Channel (US$ Million), 2021–2032
 Figure 8. Global Dry Eye Syndrome Market Share by Distribution Channel: 2025 & 2032
 Figure 9. Hospital
 Figure 10. Retail Pharmacy
 Figure 11. Others
 Figure 12. Global Dry Eye Syndrome Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Dry Eye Syndrome Market Size (US$ Million), 2021–2032
 Figure 14. Global Dry Eye Syndrome Sales (K Units), 2021–2032
 Figure 15. Global Dry Eye Syndrome Average Price (US$/Unit), 2021–2032
 Figure 16. Dry Eye Syndrome Report Years Considered
 Figure 17. Dry Eye Syndrome Sales Share by Manufacturers in 2025
 Figure 18. Global Dry Eye Syndrome Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Dry Eye Syndrome Players: Market Share by Revenue in Dry Eye Syndrome in 2025
 Figure 20. Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Dry Eye Syndrome Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Dry Eye Syndrome Sales Market Share by Country (2021–2032)
 Figure 23. North America Dry Eye Syndrome Revenue Market Share by Country (2021–2032)
 Figure 24. United States Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Dry Eye Syndrome Sales Market Share by Country (2021–2032)
 Figure 27. Europe Dry Eye Syndrome Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Dry Eye Syndrome Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Dry Eye Syndrome Revenue Market Share by Region (2021–2032)
 Figure 35. China Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Dry Eye Syndrome Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Dry Eye Syndrome Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Dry Eye Syndrome Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Dry Eye Syndrome Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Dry Eye Syndrome Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Dry Eye Syndrome by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Dry Eye Syndrome by Type (2021–2032)
 Figure 56. Global Dry Eye Syndrome Price (US$/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Dry Eye Syndrome by Distribution Channel (2021–2032)
 Figure 58. Global Revenue Market Share of Dry Eye Syndrome by Distribution Channel (2021–2032)
 Figure 59. Global Dry Eye Syndrome Price (US$/Unit) by Distribution Channel (2021–2032)
 Figure 60. Dry Eye Syndrome Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI